Moss Adams Wealth Advisors LLC Avidity Biosciences, Inc. Transaction History
Moss Adams Wealth Advisors LLC
- $1.1 Trillion
- Q2 2025
A detailed history of Moss Adams Wealth Advisors LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Moss Adams Wealth Advisors LLC holds 22,496 shares of RNA stock, worth $1.1 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
22,496
Previous 22,496
-0.0%
Holding current value
$1.1 Million
Previous $664 Million
3.79%
% of portfolio
0.06%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding RNA
# of Institutions
237Shares Held
119MCall Options Held
340KPut Options Held
145K-
Price T Rowe Associates Inc Baltimore, MD10.8MShares$527 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X010.8MShares$526 Million0.16% of portfolio
-
Rtw Investments, LP New York, NY9.62MShares$469 Million4.2% of portfolio
-
Wellington Management Group LLP Boston, MA9.25MShares$451 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.25MShares$451 Million0.0% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $2.54B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...